SB 5226 establishes a state grant program to fund physician residency positions specifically for international medical graduates (IMGs) in Washington. It requires at least 75% of funded slots in approved specialties (like family medicine, pediatrics, and psychiatry) to be filled by IMGs, with programs needing a national residency matching program waiver and accreditation. Residency programs receiving funds must report demographic data and usage details annually, and the program expires on July 1, 2032. This directly affects Washington state residency programs and IMGs seeking U.S. medical training opportunities.
SB 5185 proposes a new pathway for international medical graduates (IMGs) to obtain full medical licensure in Washington without completing standard U.S. postgraduate training. It establishes a "preceptorship pathway" requiring 48 months of supervised clinical practice under a licensed physician, followed by evaluations and board certification (ABMS or AAGP), to qualify for unrestricted licensure. The bill also creates hardship waivers for IMGs facing refugee status, persecution, or other documented barriers preventing standard documentation, excluding inability to pass ECFMG exams. This directly affects IMGs seeking to practice in Washington and the Washington Medical Commission, which would implement the new rules. The bill is currently pending in the Senate Health & Long-Term Care Committee.
SB 5242 establishes a confidential, anonymous screening program for licensed health care providers in Washington State to address mental health and burnout. The program, funded by an annual surcharge on health professional licensing fees, provides an evidence-based screening questionnaire reviewed by counselors, with options for email consultation, referrals, or assistance with paid medical leave requests for mental health needs. It directly affects all health professionals licensed under chapter 18.130 RCW, including doctors, nurses, and therapists, by offering immediate access to behavioral health resources. The program’s costs are covered through a uniform surcharge added to licensing fees, with funds dedicated exclusively to the initiative via a new state account. The bill does not create new clinical standards but aims to improve provider access to support services through a structured, confidential pathway.
HB 1675 restricts corporate ownership and control of medical practices in Washington, requiring licensed health care providers to hold majority ownership and management roles in corporate medical practices. It prohibits non-licensed entities from owning medical practices, bans conflicts of interest with management services organizations, and prevents corporations from controlling clinical decisions like patient care timing, diagnoses, or staffing. The bill directly affects medical practices structured as corporations, their shareholders/directors, and management services organizations contracting with them. It excludes hospitals, nursing homes, and certain other facilities from these provisions, focusing on protecting physicians' clinical autonomy from corporate interference.
SB 5244 amends Washington state law to exempt WIC (Women, Infants, and Children) program staff from standard licensing requirements when performing specific blood tests. It allows WIC clinic staff to conduct hematological screening tests - using heel-stick, toe-stick, or finger-stick methods - without additional licensure, directly affecting WIC program employees statewide. The bill adds this exemption to existing provisions in RCW 18.360.090, limiting the tests to basic hematological evaluations only. This change streamlines WIC staff capabilities for routine screenings within their program, effective July 27, 2025.
SB 5118 updates Washington's licensing rules to create a specific pathway for international medical graduates (IMGs) seeking clinical experience. The bill establishes a time-limited "clinical experience license" allowing IMGs who don’t yet qualify for full licensure to work under supervision at approved healthcare facilities, meeting requirements like English proficiency and passing specific exams. This directly affects IMGs aiming to complete required clinical training before obtaining full medical licensure in Washington. The license permits practice only within approved training programs and terminates after one year unless renewed, requiring continuous progress toward full licensure. The bill became law on April 4, 2025, and takes effect July 27, 2025.
SB 5387 requires that healthcare providers, not corporations or non-clinicians, own and control medical practices in Washington. It mandates that licensed providers hold majority ownership, majority of board seats, and all officer roles in professional medical corporations. The bill prohibits contracts between medical practices and management companies that would allow non-clinical entities to influence clinical decisions, such as patient care timing, diagnoses, or treatment options. Hospitals, nursing homes, and certain other facilities (like telemedicine groups) are excluded from these requirements.
SB 5513 allows pharmacists in Washington to prescribe certain medications and devices to improve patient access to care, particularly for chronic diseases and behavioral health conditions. This expands pharmacists' current authority beyond dispensing drugs, enabling them to directly prescribe within their expertise. The bill directly affects pharmacists, patients in rural and underserved communities facing provider shortages, and healthcare systems seeking to address gaps in care. Key provisions include amending state laws to define pharmacists' new prescribing powers and align with their education and training, aiming to reduce barriers to treatment without requiring additional physician visits.
HB 1888 would expand the prescriptive authority of licensed naturopathic physicians in Washington State to include controlled substances in Schedules III through V of the Uniform Controlled Substances Act. Currently, Washington naturopaths have limited prescriptive authority for certain controlled substances, but this bill would align their scope with other states by allowing them to prescribe and manage these medications, including for opioid and benzodiazepine treatment. The bill directly affects licensed naturopathic physicians who currently face restrictions compared to practitioners in neighboring states. It amends Washington Revised Code sections to explicitly include these controlled substances within the scope of naturopathic practice, while maintaining oversight by the Board of Naturopathy. This change aims to address primary care shortages and improve patient access to comprehensive care, particularly in underserved areas.
HB 1520 expands pharmacists' authority in Washington to prescribe certain medications and devices for managing chronic diseases, directly affecting patients in rural and underserved communities facing healthcare access challenges. The bill amends pharmacy law (RCW 18.64.011) to permit pharmacists to practice at the top of their training, including prescribing within defined scope for chronic conditions. Key provisions allow pharmacists to administer, dispense, and manage medications under specific protocols, improving care coordination without requiring physician oversight for these services. This change aims to address provider shortages by leveraging pharmacists' expertise to enhance patient outcomes in primary care settings.
